Thomas Krummel is a pediatric surgeon-turned-investor who helped establish one of the world's first ECMO programs for newborns and co-directed Stanford Biodesign for nearly two decades, creating a structured method for medical technology invention that produced tools now used by an estimated 7-12.6+ million patients worldwide. His dual role as chair of Fogarty Innovation's board and Venture Partner at Santé Ventures puts him at the intersection of a leading medical technology incubator and early-stage healthcare fund, allowing him to see very early concepts at Fogarty and then help shape or fund them through Santé.